CFH and neoplasm: Expression of CFH by keratinocytes and cSCC cells lines has been well documented (5, 7) and it is expected that the increased expression of this complement regulatory protein would reduce levels of anaphylatoxins within the tumor, shifting the immune response from an effective Th1-mediated to an ineffective regulatory T cell response.